February, 16th - 2 years ago
The report "GLOBAL METABOLOMICS MARKET”: Segmentation By Product (Surface Mounted Device, Led Fixture, Conventional Led Display, And Led Lighting), By Geography (Asia Pacific, North America, Europe, Middle East And Africa, South America, Forecast And Estimation 2018-2024”. Envision Inteligence estimates that Global Metabolomics Market is projected to reach $2.40 billion by the end of 2024 with a CAGR of 14.6%. Metabolomics is the study of chemical processes involving metabolites and provides information on the chemical fingerprints of various cellular processes. Download Free Sample Brochure at https://www.envisioninteligence.com/industry-report/global-metabolomics-market/ Separation technique has been the dominant and fastest growing segment during the forecast period High-performance liquid chromatography dominates the market owing to its fast adaptability. While ultra-performance liquid chromatography provides high resolution and high-efficiency separation, with a reduction in analysis time and estimated to be a fast-growing market in near future. Personalized medicine segment is anticipated to show highest growth rate over the coming years The biomarker discovery segment accounted for the largest share of the global Metabolomics market owing to rising incidence and prevalence of chronic diseases such as CVD, cancer, and diabetes, growing acceptance of cancer diagnostic tests, and scientific progression in discovery technologies. Personalized medicine is anticipated to be the fastest growing segment during the forecast period with biotech and pharma companies investing heavily in its research and development. Asia-Pacific is expected to show highest CAGR during the forecast period 2018-2024 North America and Europe has been leading market and are expected to remain to do so over the forecasting period. The substantial increase in the demand for personalized medicine is adding potential to the growth of Metabolomics market in these regions. The Asia Pacific is expected to have the highest growth due to the increase in age-related chronic illness, growing number of pharmaceutical and biotech companies, improving healthcare infrastructure and increasing investments in life sciences. The Prominent players in the Metabolomics market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.),Danaher Corporation (U.S.),Shimadzu Corporation (Japan), Metabolon Inc. (U.S.) and some others.